monocrotaline has been researched along with fumagillin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Ahmad, F; Champion, HC; Kahloon, R; Kass, DJ; Loh, K; Markowski, M; Rajkumar, R; Rattigan, E; Saqi, A; Savir, A; Yu, L | 1 |
2 other study(ies) available for monocrotaline and fumagillin
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Early treatment with fumagillin, an inhibitor of methionine aminopeptidase-2, prevents Pulmonary Hypertension in monocrotaline-injured rats.
Topics: Aminopeptidases; Animals; Cell Proliferation; Cells, Cultured; Cyclohexanes; Disease Models, Animal; Fatty Acids, Unsaturated; Gene Expression Regulation; Glycoproteins; Heart Ventricles; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Monocrotaline; Myocytes, Cardiac; Myocytes, Smooth Muscle; Myofibroblasts; Platelet-Derived Growth Factor; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Sesquiterpenes | 2012 |